Article
Targeting telomerase for its advent in cancer therapeutics
11 May 2020
Abstract excerpt
Telomerase has emerged as an important primary target in anticancer therapy. It is a distinctive reverse transcriptase enzyme, which extends the length of telomere at the 3' chromosomal end, and uses telomerase reverse transcriptase (TERT) and telomerase RNA template-containing domains. Telomerase has a vital role and is a contributing factor in human health, mainly affecting cell aging and cell proliferation....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
